Public court records · Regulatory sources · Independently maintained Data as of: 2026-10-03 · Not legal advice
VerdictWiki Browse cases

NEC Baby Formula (Enfamil / Similac) Lawsuit

US filed Last verified 2026-10-03

Multiple U.S. federal and state courts

NEC baby formula lawsuits: families of premature infants claim that cow’s-milk-based formulas — Enfamil (Mead Johnson, Reckitt) and Similac (Abbott) — are associated with necrotizing enterocolitis (NEC), a life-threatening intestinal disease in premature babies, and that the makers failed to warn (per complaints and firm pages)..

Overview

NEC baby formula lawsuits: families of premature infants claim that cow’s-milk-based formulas — Enfamil (Mead Johnson, Reckitt) and Similac (Abbott) — are associated with necrotizing enterocolitis (NEC), a life-threatening intestinal disease in premature babies, and that the makers failed to warn (per complaints and firm pages). Individual lawsuits are being filed across U.S. federal and state courts; as of September 2026 no consolidated MDL is on the public record and no global settlement has been reported (per firm pages and the JPML pending list). We track the public record — we do not promise or predict outcomes.

Status of the science / claims: NEC (necrotizing enterocolitis) is a life-threatening intestinal disease of premature infants. Plaintiff theories allege that cow’s-milk-based formulas are associated with increased NEC risk and that the makers failed to warn (per complaints and firm pages). Causation is contested and no controlling determination has been made (per the docket posture).

Companies involved

Reckitt (defendant)
Official site ↗ Wikipedia ↗ Regulatory history & cases →
Abbott Laboratories (co_defendant)
Official site ↗ Wikipedia ↗ Regulatory history & cases →

Settlement amounts

No settlement or payout program is on the public record as of September 2026 (per firm pages and the JPML pending list). No amount can be promised.

Figures above are as reported by the cited sources — not a promise of any individual outcome.

Last updated: 2026-09-01

Full breakdown: settlement amounts page →

Key dates

  1. September 1, 2026Claims continue in state and federal courts; plaintiff firms advertise intake; no consolidated MDL is on the public record (per firm pages, Sep 2026)
  2. January 1, 2025Families begin filing NEC claims against the makers of Enfamil (Mead Johnson/Reckitt) and Similac (Abbott) (per firm pages)

Updates

  • Updated Oct 3, 2026New case (Oct 2026, US): NEC baby formula (Enfamil/Similac) — premature-infant NEC claims active in state and federal courts; no MDL on the public record (per firm pages).

Last updated: today

Full changelog →

Notable filings

No notable filings recorded yet. Docket entries are added from public court records as they appear.

FAQ

Frequently asked questions about this case record, answered from the public record.

What is the NEC baby formula lawsuit?

Families of premature infants are suing the makers of Enfamil and Similac, claiming the formulas are associated with necrotizing enterocolitis (NEC) and that the makers failed to warn (per complaints and firm pages). Cases are being filed in U.S. federal and state courts.

Which formula brands are involved?

Enfamil (Mead Johnson, a Reckitt brand) and Similac (Abbott) are the main brands named in the NEC claims; claims involving other formulas (e.g., Neocate) are also reported (per firm pages, 2026).

Is there an MDL or settlement for NEC formula claims?

No consolidated MDL is on the public record as of September 2026, and no global settlement has been reported (per firm pages and the JPML pending list). No amount can be promised.

Think this matters to you?

This page is neutral reference material — not legal advice. If you were affected, the next step is a free case review with a licensed attorney working this matter.

Start free case review →

By continuing you agree to our privacy policy. Your contact details are shared only with law firms working this matter, on request.